TrialClinical and translational science2026

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fenebrutinib and Effect on the QT/QTc Interval in Healthy Participants.

Yan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.